GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (LTS:0QBO) » Definitions » ROE % Adjusted to Book Value

Coloplast A/S (LTS:0QBO) ROE % Adjusted to Book Value : 2.48% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast A/S ROE % Adjusted to Book Value?

Coloplast A/S's ROE % for the quarter that ended in Mar. 2024 was 31.97%. Coloplast A/S's PB Ratio for the quarter that ended in Mar. 2024 was 12.89. Coloplast A/S's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 2.48%.


Coloplast A/S ROE % Adjusted to Book Value Historical Data

The historical data trend for Coloplast A/S's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S ROE % Adjusted to Book Value Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.28 2.02 2.37 2.89 3.85

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.48 2.55 4.26 2.59 2.48

Competitive Comparison of Coloplast A/S's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Coloplast A/S's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's ROE % Adjusted to Book Value falls into.



Coloplast A/S ROE % Adjusted to Book Value Calculation

Coloplast A/S's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=37.38% / 9.71
=3.85%

Coloplast A/S's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=31.97% / 12.89
=2.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast A/S ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (LTS:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (LTS:0QBO) Headlines

No Headlines